RetinalGenix Technologies Inc. (RTGN)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$2.43M | -$4.32M | -$2.09M | -$3.91M | -$2.18M | -$2.08M | — |
| EPS (Diluted) | $-0.13 | $-0.24 | $-0.12 | $-0.25 | $-0.05 | — | — |
| Total Assets | $21.0K | $14.9K | $156 | $294 | $4.9K | $61.1K | — |
| Total Liabilities | $2.32M | $1.48M | $1.41M | $1.07M | $469.6K | $141.4K | — |
| Shareholders' Equity | -$2.30M | -$1.46M | -$1.41M | -$1.07M | -$464.7K | -$80.4K | $24.2K |
| Cash & Equivalents | — | — | — | $38 | $4.9K | $2.2K | — |
| Operating Cash Flow | -$558.4K | -$741.9K | -$451.7K | -$199.3K | -$1.17M | -$1.42M | — |
| Shares Outstanding | 18.75M | 18.52M | 17.64M | 17.27M | 14.22M | 40.68M | — |